Table 1

Patient characteristics

PatientAge (yr)Sex (M/F)Presenting features at diagnosisExpression frequency of surface antigens (% blasts positive)
WBC (× 103/μl)HSMaMMNCI risk classificationCD7 pan-TCD10/CALLACD19 pan-B
T-ALL#112.0MNA(ALL in first bone marrow relapse)85661
T-ALL#25.0MNA(ALL in first bone marrow relapse)9001
T-ALL#311.0F550+Poor9301
T-ALL#43.0M71Poor94111
T-ALL#53.6M574++Poor9027
T-ALL#611.0F7++Poor99961
T-ALL#71.8M706++Poor7912
T-ALL#87.4F95++Poor9421
T-ALL#94.8M324++Poor98981
T-ALL#1010.8F193Poor3128
T-ALL#115.4F425+Poor89781
T-ALL#124.9M510++Poor96111
T-ALL#1310.9M281++Poor9644
T-ALL#1419.0MNA(ALL in first bone marrow relapse)73010
T-ALL#154.6M144++Poor7313
T-ALL#169.2F500+Poor9820
T-ALL#1711.1M819++Poor7981
T-ALL#1810.0M630++Poor9045
  • a HSM, hepatosplenomegaly; NA, not applicable; WBC, white blood cell count; MM, mediastinal mass; NCI, National Cancer Institute.